Analyse Fortrea Holdings Inc. (FTRE) — Kairos Score 64/100

À propos de Fortrea Holdings Inc.

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Informations clés

🕴️ Activité des initiés (90 jours)

4 transactions — 0 achats et 2 ventes déclarés par les dirigeants de Fortrea Holdings Inc..

🏦 Hedge Funds

32 fonds institutionnels déclarent une position sur FTRE dans leur dernière déclaration trimestrielle SEC.

📰 Actualités récentes

15 articles récents sur FTRE.

• Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials
• Is Fortrea Holdings (FTRE) Still Cheap After Its 116% Run?

🧠 Ce qui fait Kairos Insider

Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.